Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the Synapse in Alzheimer’s Disease
Johanna Jackson, Enrique Jambrina, Jennifer Li, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 192

Showing 1-25 of 192 citing articles:

Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
Priyanka Rawat, Ujala Sehar, Jasbir Bisht, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12841-12841
Open Access | Times Cited: 173
The synapse in traumatic brain injury
Aimun A. B. Jamjoom, Jonathan Rhodes, Peter Andrews, et al.
Brain (2020) Vol. 144, Iss. 1, pp. 18-31
Open Access | Times Cited: 169
Resting state EEG biomarkers of cognitive decline associated with Alzheimer’s disease and mild cognitive impairment
Amir H. Meghdadi, Marija Stevanović Karić, Marissa McConnell, et al.
PLoS ONE (2021) Vol. 16, Iss. 2, pp. e0244180-e0244180
Open Access | Times Cited: 167
Reelin Functions, Mechanisms of Action and Signaling Pathways During Brain Development and Maturation
Yves Jossin
Biomolecules (2020) Vol. 10, Iss. 6, pp. 964-964
Open Access | Times Cited: 140
Modeling Sporadic Alzheimer's Disease in Human Brain Organoids under Serum Exposure
Xianwei Chen, Guoqiang Sun, E Tian, et al.
Advanced Science (2021) Vol. 8, Iss. 18
Open Access | Times Cited: 122
Alzheimer’s disease as a synaptopathy: Evidence for dysfunction of synapses during disease progression
S. Meftah, Jian Gan
Frontiers in Synaptic Neuroscience (2023) Vol. 15
Open Access | Times Cited: 70
Biomarkers used in Alzheimer’s disease diagnosis, treatment, and prevention
Yacoubou Abdoul Razak Mahaman, Kidane Siele Embaye, Huang Fang, et al.
Ageing Research Reviews (2021) Vol. 74, pp. 101544-101544
Closed Access | Times Cited: 98
Protective genes and pathways in Alzheimer’s disease: moving towards precision interventions
Mabel Seto, Rebecca L. Weiner, Logan Dumitrescu, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 93
Microglial physiological properties and interactions with synapses are altered at presymptomatic stages in a mouse model of Huntington’s disease pathology
Julie C. Savage, Marie‐Kim St‐Pierre, Micaël Carrier, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 86
An App knock-in rat model for Alzheimer’s disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments
Keliang Pang, Richeng Jiang, Wei Zhang, et al.
Cell Research (2021) Vol. 32, Iss. 2, pp. 157-175
Open Access | Times Cited: 85
Whole‐genome sequencing reveals new Alzheimer's disease–associated rare variants in loci related to synaptic function and neuronal development
Dmitry Prokopenko, Sarah Morgan, Kristina Mullin, et al.
Alzheimer s & Dementia (2021) Vol. 17, Iss. 9, pp. 1509-1527
Open Access | Times Cited: 77
Neurovascular dysfunction and vascular amyloid accumulation as early events in Alzheimer's disease
Ricardo Apátiga-Pérez, Luis O. Soto-Rojas, B. Berenice Campa-Córdoba, et al.
Metabolic Brain Disease (2021) Vol. 37, Iss. 1, pp. 39-50
Closed Access | Times Cited: 69
New insights into the role and mechanisms of ginsenoside Rg1 in the management of Alzheimer’s disease
Jiaojiao Wu, Yang Yu, Yan Wan, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 152, pp. 113207-113207
Open Access | Times Cited: 64
A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer’s disease
Niels D. Prins, John Harrison, Hui‐May Chu, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 61
Prebiotic Lactulose Ameliorates the Cognitive Deficit in Alzheimer’s Disease Mouse Model through Macroautophagy and Chaperone-Mediated Autophagy Pathways
Yan-Suan Lee, Dar-Ming Lai, Hei-Jen Huang, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 8, pp. 2422-2437
Closed Access | Times Cited: 60
Imaging Synaptic Density: The Next Holy Grail of Neuroscience?
Maria Elisa Serrano Navacerrada, Eugene Kim, Marija M. Petrinovic, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 43
Propagation of tau and α-synuclein in the brain: therapeutic potential of the glymphatic system
Douglas M. Lopes, Sophie K. Llewellyn, Ian F. Harrison
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 41
Microglia: A pharmacological target for the treatment of age-related cognitive decline and Alzheimer’s disease
Chloe McKee, Madison Hoffos, Haley A. Vecchiarelli, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 22
Oligodendrocyte progenitor cells in Alzheimer’s disease: from physiology to pathology
Peibin Zou, Chongyun Wu, Timon Cheng‐Yi Liu, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 22
The role of synaptic microRNAs in Alzheimer's disease
Subodh Kumar, P. Hemachandra Reddy
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2020) Vol. 1866, Iss. 12, pp. 165937-165937
Open Access | Times Cited: 62
Interplay between Peripheral and Central Inflammation in Obesity-Promoted Disorders: The Impact on Synaptic Mitochondrial Functions
Marianna Crispino, Giovanna Trinchese, Eduardo Penna, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 5964-5964
Open Access | Times Cited: 59
Traumatic brain injury and post‐traumatic stress disorder are not associated with Alzheimer's disease pathology measured with biomarkers
Michael W. Weiner, Danielle Harvey, Susan Landau, et al.
Alzheimer s & Dementia (2022) Vol. 19, Iss. 3, pp. 884-895
Open Access | Times Cited: 34
Connecting the Dots Between Hypercholesterolemia and Alzheimer’s Disease: A Potential Mechanism Based on 27-Hydroxycholesterol
Mingan Wu, Yingying Zhai, Xiaoyi Liang, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 33
Ion flux-independent NMDA receptor signaling
Deborah K. Park, Ivar S. Stein, Karen Zito
Neuropharmacology (2022) Vol. 210, pp. 109019-109019
Open Access | Times Cited: 29
Synaptosome microRNAs regulate synapse functions in Alzheimer’s disease
Subodh Kumar, Erika Orlov, Prashanth Gowda, et al.
npj Genomic Medicine (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top